Super-resolution microscopy reveals how a cancer drug triggers cellular breakdown
Cancer drugs are often designed to block specific molecular targets, but what happens after they enter a cell is not always well understood. A new study published in Biophotonics Discovery demonstrates how advanced imaging technology can help answer that question.
A new study published in Biophotonics Discovery reveals how super-resolution microscopy can provide insights into how cancer drugs affect cells at the microscopic level. Researchers from the Diao Laboratory at the University of Cincinnati used this advanced imaging technology to track the cancer drug sunitinib as it entered living cells and observed its impact on several key cellular structures.
Sunitinib, a drug used to treat various cancers like kidney cancer, is known for its ability to inhibit enzymes driving tumor growth. However, researchers have recently discovered that how a drug moves within a cell can also influence its effectiveness and side effects. To investigate, the team combined cell viability testing with structured illumination microscopy (SIM), a super-resolution imaging technique capable of visualizing structures too small for conventional light microscopes.
The drug's natural fluorescence allowed the researchers to monitor its movement inside cells without chemically modifying it. The study focused on three interconnected cellular systems: lysosomes, mitochondria, and the endoplasmic reticulum (ER). The findings showed that sunitinib primarily accumulated in lysosomes and caused a dose-dependent loss of cell viability, with higher concentrations leading to greater cell death.
Under super-resolution imaging, the drug caused mitochondrial networks to become fragmented, and the lysosomes to decrease in number while becoming larger and more irregular. Similarly, the ER network also disintegrated into disconnected fragments. These structural changes suggest that sunitinib triggers coordinated disruption of multiple cellular systems, ultimately contributing to cell collapse.
The research highlights the growing role of optical imaging in drug development and cellular engineering, demonstrating how super-resolution microscopy can reveal interactions invisible to conventional microscopy. This method could help researchers better understand drug success, failure, and side effects, supporting the development of more effective therapies.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
